v2.4.0.6
Asset Impairments and Restructuring Charges
12 Months Ended
Feb. 02, 2013
Asset Impairments and Restructuring Charges
2. Asset Impairments and Restructuring Charges

During the third quarter of fiscal 2012, the Company recorded a $44.9 million impairment charge as a result of the Company’s interim impairment test of its Micromania trade name. The fair value of the Micromania trade name was calculated using a relief-from-royalty approach, which assumes the fair value of the trade name is the discounted cash flows of the amount that would be paid by a hypothetical market participant had they not owned the trade name and instead licensed the trade name from another company. Refer to Note 9, Goodwill, Intangible Assets and Deferred Financing Fees, for further information associated with the trade name impairment. In fiscal 2012, the Company also recorded impairments of definite-lived assets of $8.8 million, consisting primarily of the remaining net book value of assets for stores the Company is in the process of closing or that the Company has determined will not have sufficient cash flow on an undiscounted basis to cover the remaining net book value of assets recorded for that store. The Company used a discounted cash flow method to estimate the present value of net cash flows that the fixed asset or fixed asset group is expected to generate in determining its fair value. The key inputs to the discounted cash flow model generally included our forecasts of net cash generated from revenue, expenses and other significant cash outflows, such as capital expenditures, as well as an appropriate discount rate. There were no restructuring charges for the 53 weeks ended February 2, 2013.

A summary of the Company’s asset impairments for the 53 weeks ended February 2, 2013 is as follows:

 

     United States      Canada      Australia      Europe      Total  
     (In millions)  

Intangible asset impairment

   $       $       $       $ 44.9       $ 44.9   

Property, equipment and other asset impairments

     5.7         0.4         0.2         2.5         8.8   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 5.7       $ 0.4       $ 0.2       $ 47.4       $ 53.7   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

In the fourth quarter of fiscal 2011, the Company recorded asset impairments and restructuring charges of $81.2 million, of which $37.8 million was recorded as a result of the Company’s annual impairment test of its Micromania trade name. The fair value of the Micromania trade name was calculated using a relief-from-royalty approach, which assumes the fair value of the trade name is the discounted cash flows of the amount that would be paid by a hypothetical market participant had they not owned the trade name and instead licensed the trade name from another company. Refer to Note 9, Goodwill, Intangible Assets and Deferred Financing Fees, for further information associated with the trade name impairment. In addition, $22.7 million was recorded related to the impairment of investments in non-core businesses, primarily a small retail movie chain of stores owned by the Company until fiscal 2011. The Company also incurred restructuring charges in the fourth quarter of fiscal 2011 related to the exit of certain markets in Europe and the closure of underperforming stores in the international segments, as well as the consolidation of European home office sites and back-office functions. These restructuring charges were a result of management’s plan to rationalize the international store base and improve profitability. In addition, the Company recognized impairment charges related to its annual evaluation of store property, equipment and other assets in situations where the asset’s carrying value was not expected to be recovered by its future cash flows over its remaining useful life.

A summary of the Company’s asset impairments and restructuring charges for the 52 weeks ended January 28, 2012 is as follows:

 

     United States      Canada      Australia      Europe      Total  
     (In millions)  

Intangible asset impairment

   $       $       $       $ 37.8       $ 37.8   

Impairment of investments in non-core businesses

     22.7                                 22.7   

Property, equipment and other asset impairments

     3.2         1.1         0.5         6.4         11.2   

Termination benefits

     3.0         0.2                 2.4         5.6   

Facility closure and other costs

                     0.1         3.8         3.9   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 28.9       $ 1.3       $ 0.6       $ 50.4       $ 81.2   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

The Company’s accrual for termination benefits and facility closure and other costs was recorded as a current liability within accrued liabilities on its consolidated balance sheet as of January 28, 2012 in the amount of $9.5 million. The following table summarizes the balance of accrued expenses related to the restructuring initiative and the changes in the accrued expenses as of and for the 53 weeks ended February 2, 2013 (in millions):

 

     Accrued
Balance as of
January 28,
2012
     Activity for the 53 Weeks Ended February 2, 2013     Accrued
Balance as of
February 2,
2013
 
        Charges      Cash
Payments
    Non-cash and
Foreign
Currency
Changes
   

Termination benefits

   $ 5.6       $       $ (4.6   $ (0.1   $ 0.9   

Facility closure and other costs

     3.9                 (2.2     (1.7       
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Total

   $ 9.5       $       $ (6.8   $ (1.8   $ 0.9   
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

The Company also recognized impairment charges in fiscal 2010 of $1.5 million related to its annual evaluation of store property, equipment and other assets in situations where the asset’s carrying value was not expected to be recovered by its future discounted cash flows over its remaining useful life. These charges were primarily related to the Company’s stores in the European segment.